Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-07-15
1999-11-30
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 2, A61K 3812, A61K 3814, C07K 900
Patent
active
059942975
ABSTRACT:
The present invention is directed to methods for treating infections caused by Staphylococcus aureus with reduced glycopeptide sensitivity. The invention is preferably practiced with strains of Staphylococcus aureus which are methicillin resistant, such as the Mu5O strain.
REFERENCES:
Abstracts of the 37hu th ICAAC, C-164, Sep. 28-Oct. 1, 1997, p. 74.
J. Antimicrob Chemother, Hiramatsu et al, 1997; 40:135-136.
Ann Intern Med., M.B. Edmond et al, 1996; 124:329-334.
FEMS Microbiology Letters, Noble et al, 93 (1992) 195-198.
New England J. Medicine, Schwalbe et al, 1987, vol. 316, No. 15, pp. 927-931.
J. Clin Microbiol., Veach et al, Sep. 1990, vol. 28, No. 9, pp. 2064-2068.
The Lancet, Jan. 5, 1991, vol. 337, p. 54.
Exp. Opin. Ther. Patents 6(1), 73-75 (1996).
Jones, Ronald N., et al., Antimicrobial Agents and Chemotherapy, 41(2), 488-493 (1996).
Biavasco, Francesca, et al., Antimicrobial Agents and Chemotherapy, 41(10), 2165-2172 (1997).
Nicas Thalia Ioanna
Preston David Albert
Zeckel Michael Lee
Borin Michael
Eli Lilly and Company
Musser Arlene K.
Woodward Michael P.
LandOfFree
Therapy for Staphylococcus aureus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapy for Staphylococcus aureus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapy for Staphylococcus aureus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672477